• Japanese
  • Korean
  • Chinese
Cover Image

Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment

Abstract

The dermatology industry's psoriasis sector will continue to grow despite patent expiries for key treatments, as impressive R&D spending reinforces product pipelines, states the latest report from pharmaceutical industry analysts GBI Research.

The company's latest study* predicts the psoriasis sector's global revenue will maintain respectable growth over the next few years, climbing from a 2011 total of $4.6 billion to $6 billion in 2018, at a Compound Annual Growth Rate (CAGR) of 4%.

GBI Research attributes growth in the face of product expiries to the relatively recent release of key treatments, such as Janssen Biotech's Stelara in 2009, and several promising molecules including AIN457, tofacitinib, CF101 and anti-CD6 monoclonal antibody, which are currently in development and are expected to be launched by 2014.

Additionally, the report highlights the growing global population as a key factor determining psoriasis industry revenue - as the number of people increases, so does the amount of those with psoriasis. The prevalence of psoriasis was estimated to be 6.7 million people in 2011, but this is expected to climb at a CAGR of 0.4%, reaching 6.9 million by the end of 2018.

Due to the more physically obvious and unpleasant aspects of psoriasis, those afflicted are also more likely to seek medical help than people suffering from conditions with less obvious symptoms, and as there is currently no cure, patients must seek treatment for life.

The dermatology therapeutics market as a whole jumped from a 2004 value of $11.4 billion to $15.8 billion in 2011. By 2018, GBI Research expects this figure to reach $19.1 billion.

* Dermatology Therapeutics Market to 2018 - Novel Biologics Targeting Interleukin-17 Receptor Presents New Options in Psoriasis Treatment.

This report provides insights into the dermatology therapeutics market including market forecasts up to 2018.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research's team of industry experts.

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Dermatology Therapeutics Market to 2018 - Introduction

3. Dermatology Therapeutics Market to 2018 - Market Overview

  • 3.1. Revenue
  • 3.2. Annual Cost of Treatment
  • 3.3. Treatment Usage Pattern
    • 3.3.1. Diseased Population
    • 3.3.2. Treatment-Seeking Population
    • 3.3.3. Diagnosed Population
    • 3.3.4. Prescription Population
  • 3.4. Recently Approved Product
    • 3.4.1. Fabior (Tazarotene)
  • 3.5. Key Trends
    • 3.5.1. Potential New Treatment for Skin Diseases
    • 3.5.2. Innovative Medicines Initiative Launched in Europe to Address Antibiotic Resistance

4. Dermatology Therapeutics Market to 2018 - Geographical Landscape

  • 4.1. Revenue by Country
  • 4.2. The US
    • 4.2.1. Revenue
    • 4.2.2. Annual Cost of Treatment
    • 4.2.3. Treatment Usage Pattern
  • 4.3. Top Five Countries in Europe
    • 4.3.1. Revenue
    • 4.3.2. Annual Cost of Treatment
    • 4.3.3. Treatment Usage Pattern
  • 4.4. Japan
    • 4.4.1. Revenue
    • 4.4.2. Annual Cost of Treatment
    • 4.4.3. Treatment Usage Pattern

5. Dermatology Therapeutics Market to 2018 - Therapeutic Landscape

  • 5.1. Global Alopecia Therapeutics Market
    • 5.1.1. Introduction
    • 5.1.2. Revenue
    • 5.1.3. Annual Cost of Treatment
    • 5.1.4. Treatment Usage Pattern
    • 5.1.5. Treatment Algorithm
    • 5.1.6. Drivers and Restraints
  • 5.2. Global Herpes Therapeutics Market
    • 5.2.1. Introduction
    • 5.2.2. Revenue
    • 5.2.3. Annual Cost of Treatment
    • 5.2.4. Treatment Usage Pattern
    • 5.2.5. Treatment Algorithm
    • 5.2.6. Drivers and Restraints
  • 5.3. Global Psoriasis Therapeutics Market
    • 5.3.1. Introduction
    • 5.3.2. Revenue
    • 5.3.3. Annual Cost of Treatment
    • 5.3.4. Treatment Usage Pattern
    • 5.3.5. Treatment Algorithm
    • 5.3.6. Drivers and Restraints
  • 5.4. Global Acne Therapeutics Market
    • 5.4.1. Introduction
    • 5.4.2. Revenue
    • 5.4.3. Annual Cost of Treatment
    • 5.4.4. Treatment Usage Pattern
    • 5.4.5. Treatment Algorithm
    • 5.4.6. Drivers and Restraints
  • 5.5. Global Rosacea Disease Therapeutics Market
    • 5.5.1. Introduction
    • 5.5.2. Revenue
    • 5.5.3. Annual Cost of Treatment
    • 5.5.4. Treatment Usage Pattern
    • 5.5.5. Treatment Algorithm
    • 5.5.6. Drivers and Restraints
  • 5.6. Global Atopic Dermatitis Therapeutics Market
    • 5.6.1. Introduction
    • 5.6.2. Revenue
    • 5.6.3. Annual Cost of Treatment
    • 5.6.4. Treatment Usage Pattern
    • 5.6.5. Treatment Algorithm
    • 5.6.6. Drivers and Restraints

6. Dermatological Therapeutics Market - Asia-Pacific Countries

  • 6.1. India
    • 6.1.1. Healthcare Overview
    • 6.1.2. Regulatory Landscape
    • 6.1.3. Market Overview
    • 6.1.4. Key Trends
    • 6.1.5. Company Analysis
    • 6.1.6. Drivers and Restraints
  • 6.2. China
    • 6.2.1. Market Overview
    • 6.2.2. Key Trends
  • 6.3. Australia
    • 6.3.1. Market Overview
    • 6.3.2. Pricing and Reimbursement

7. Dermatological Therapeutics Market to 2018 - Pipeline Analysis

  • 7.1. Introduction
    • 7.1.1. Research and Development Pipeline - Alopecia
    • 7.1.2. Research and Development Pipeline - Herpes
    • 7.1.3. Research and Development Pipeline - Psoriasis
    • 7.1.4. Research and Development Pipeline - Acne vulgaris
    • 7.1.5. Research and Development Pipeline - Rosacea
    • 7.1.6. Research and Development Pipeline - Atopic Dermatitis
  • 7.2. Key R&D Trends
  • 7.3. Promising Molecules - NDA Filed
    • 7.3.1. LAS 41002
    • 7.3.2. Low-Dose Duac
    • 7.3.3. Acnex
  • 7.4. Promising Molecules - Phase III
    • 7.4.1. Zoster
    • 7.4.2. ARYS-01
    • 7.4.3. V212
    • 7.4.4. CC-10004
    • 7.4.5. CD07805/47
  • 7.5. Promising Molecules - Phase II
    • 7.5.1. EPB-348
    • 7.5.2. AMG 827
    • 7.5.3. V-101
    • 7.5.4. MK-3222

8. Dermatology Therapeutics Market to 2018 - Competitive Landscape

  • 8.1. Market Share Analysis: Dermatological Disorders
  • 8.2. Competitive Profiling
    • 8.2.1. Johnson & Johnson
    • 8.2.2. Amgen
    • 8.2.3. Merck & Co
    • 8.2.4. Abbott Laboratories
    • 8.2.5. Pfizer
    • 8.2.6. GlaxoSmithKline
    • 8.2.7. Novartis
    • 8.2.8. Medicis
    • 8.2.9. Galderma

9. Dermatology Therapeutics Market to 2018 - Deals Analysis

  • 9.1. Mergers and Acquisitions
    • 9.1.1. Mergers and Acquisitions by Indication
    • 9.1.2. Mergers and Acquisitions by Type
    • 9.1.3. Mergers and Acquisitions by Value
    • 9.1.4. Mergers and Acquisitions by Geography
    • 9.1.5. Major Mergers and Acquisitions Deals
  • 9.2. Licensing Agreements
    • 9.2.1. Licensing Agreements by Indication
    • 9.2.2. Licensing Agreements by Year
    • 9.2.3. Licensing Agreements by Value
    • 9.2.4. Licensing Agreements by Geography
    • 9.2.5. Major Licensing Agreements

10. Aesthetic Dermatology

  • 10.1. Introduction
  • 10.2. Drivers and Restraints
    • 10.2.1. Drivers
    • 10.2.2. Restraints
  • 10.3. Botulinum Toxin
    • 10.3.1. Major Marketed Products
    • 10.3.2. Most Promising Molecules
  • 10.4. Dermal Fillers
    • 10.4.1. Temporary Biodegradable Fillers
    • 10.4.2. Semi-Permanent Biodegradable Fillers
  • 10.5. Breast Augmentation
    • 10.5.1. Style 410
    • 10.5.2. Breast Implants Linked to Lymphoma Risk

11. Dermatology Therapeutics Market to 2017 - Appendix

  • 11.1. Market Definitions
  • 11.2. Abbreviations
  • 11.3. Bibliography
  • 11.4. Research Methodology
    • 11.4.1. Coverage
    • 11.4.2. Secondary Research
    • 11.4.3. Primary Research
  • 11.5. Therapeutic Landscape
    • 11.5.2. Market Size by Geography
  • 11.6. Geographical Landscape
  • 11.7. Pipeline Analysis
  • 11.8. Competitive Landscape
    • 11.8.1. Expert Panel Validation
  • 11.9. Contact Us
  • 11.10. Disclaimer

List of Tables

  • Table 1: Dermatology Therapeutics Market, Global, Revenue ($bn), 2004-2011
  • Table 2: Dermatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
  • Table 3: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011
  • Table 4: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018
  • Table 5: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011
  • Table 6: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018
  • Table 7: Dermatology Therapeutics Market, Revenue by Geography ($bn), 2004-2011
  • Table 8: Dermatology Therapeutics Market, Revenue Forecasts by Geography ($bn), 2011-2018
  • Table 9: Dermatology Therapeutics Market, the US, Revenue ($bn), 2004-2011
  • Table 10: Dermatology Therapeutics Market, The US, Revenue Forecasts ($bn), 2011-2018
  • Table 11: Dermatology Therapeutics Market, The US, Annual Cost of Treatment ($), 2004-2011
  • Table 12: Dermatology Therapeutics Market, The US, Annual Cost of Treatment ($), 2011-2018
  • Table 13: Dermatology Therapeutics Market, the US, Treatment Usage Pattern (million), 2004-2011
  • Table 14: Dermatology Therapeutics Market, the US, Treatment Usage Pattern (million), 2011-2018
  • Table 15: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue ($m), 2004-2011
  • Table 16: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts ($m), 2011-2018
  • Table 17: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue by Country ($bn), 2004-2011
  • Table 18: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts by Country ($bn), 2011-2018
  • Table 19: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2004-2011
  • Table 20: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2011-2018
  • Table 21: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2004-2011
  • Table 22: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2011-2018
  • Table 23: Dermatology Therapeutics Market, Japan, Revenue ($bn), 2004-2011
  • Table 24: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($bn), 2011-2018
  • Table 25: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2004-2011
  • Table 26: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2011-2018
  • Table 27: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2004-2011
  • Table 28: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2011-2018
  • Table 29: Alopecia Therapeutics Market, Global, Revenue ($bn), 2004-2011
  • Table 30: Alopecia Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
  • Table 31: Alopecia Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011
  • Table 32: Alopecia Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018
  • Table 33: Alopecia Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011
  • Table 34: Alopecia Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018
  • Table 35: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011
  • Table 36: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018
  • Table 37: Herpes Therapeutics Market, Global, Revenue ($bn), 2004-2011
  • Table 38: Herpes Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
  • Table 39: Herpes Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011
  • Table 40: Herpes Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018
  • Table 41: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011
  • Table 42: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018
  • Table 43: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011
  • Table 44: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018
  • Table 45: Psoriasis Therapeutics Market, Global, Revenues ($bn), 2004-2011
  • Table 46: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
  • Table 47: Psoriasis Therapeutics Market, Global, Marketed Products, 2012
  • Table 48: Psoriasis Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011
  • Table 49: Psoriasis Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018
  • Table 50: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011
  • Table 51: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018
  • Table 52: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011
  • Table 53: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011
  • Table 54: Acne Therapeutics Market, Global, Revenue ($bn), 2004-2011
  • Table 55: Acne Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
  • Table 56: Acne Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011
  • Table 57: Acne Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018
  • Table 58: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011
  • Table 59: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018
  • Table 60: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011
  • Table 61: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018
  • Table 62: Rosacea Therapeutics Market, Global, Revenue ($bn), 2004-2011
  • Table 63: Rosacea Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
  • Table 64: Rosacea Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011
  • Table 65: Rosacea Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018
  • Table 66: Rosacea Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011
  • Table 67: Rosacea Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018
  • Table 68: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011
  • Table 69: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018
  • Table 70: Atopic Dermatitis Therapeutics Market, Global, Revenue ($m), 2004-2011
  • Table 71: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2011-2018
  • Table 72: Atopic Dermatitis Therapeutics Market, Global, Revenue by Geography ($m), 2004-2011
  • Table 73: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2011-2018
  • Table 74: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2011
  • Table 75: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2011-2018
  • Table 76: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2011
  • Table 77: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018
  • Table 78: Dermatology Therapeutics Market to 2018, NLEM, Dermatological Medicines Topical, India, 2011
  • Table 79: Dermatology Therapeutics Market to 2018, Marketed Products, Glenmark, India, 2012
  • Table 80: Dermatology Therapeutics Market to 2018, Marketed Products, Galderma, India, 2012
  • Table 81: Dermatology Therapeutics Market to 2018, Major Marketed Products, Australia, 2012
  • Table 82: Dermatology Therapeutics Market to 2018, PBS Reimbursement List, Australia, 2012
  • Table 83: Dermatology Therapeutics Market, Global, Other Manufacturers, 2011

List of Figures

  • Figure 1: Dermatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018
  • Figure 2: Dermatology Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018
  • Figure 3: Dermatology Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018
  • Figure 4: Dermatology Therapeutics Market, Revenue Forecasts by Geography ($bn), 2004-2018
  • Figure 5: Dermatology Therapeutics Market, the US, Revenue Forecasts ($bn), 2004-2018
  • Figure 6: Dermatology Therapeutics Market, the US, Annual Cost of Treatment ($), 2004-2018
  • Figure 7: Dermatology Therapeutics Market, the US, Treatment Usage Pattern (million), 2004-2018
  • Figure 8: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts ($bn), 2004-2018
  • Figure 9: Dermatology Therapeutics Market, Top Five Countries in Europe, Revenue Forecasts by Country ($bn), 2004-2018
  • Figure 10: Dermatology Therapeutics Market, Top Five Countries in Europe, Annual Cost of Treatment ($), 2004-2018
  • Figure 11: Dermatology Therapeutics Market, Top Five Countries in Europe, Treatment Usage Pattern (million), 2004-2018
  • Figure 12: Dermatology Therapeutics Market, Japan, Revenue Forecasts ($bn), 2004-2018
  • Figure 13: Dermatology Therapeutics Market, Japan, Annual Cost of Treatment ($), 2004-2018
  • Figure 14: Dermatology Therapeutics Market, Japan, Treatment Usage Pattern (million), 2004-2018
  • Figure 15: Alopecia Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018
  • Figure 16: Alopecia Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018
  • Figure 17: Alopecia Therapeutics Market, Global, Revenue Segmentation (%), 2011 and 2018
  • Figure 18: Alopecia Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018
  • Figure 19: Alopecia Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018
  • Figure 20: Alopecia Therapeutics Market, Global, Treatment Algorithm
  • Figure 21: Alopecia Therapeutics Market, Drivers and Restraints, 2012
  • Figure 22: Herpes Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018
  • Figure 23: Herpes Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018
  • Figure 24: Herpes Therapeutics Market, Global, Revenue Segmentation (%), 2011 and 2018
  • Figure 25: Herpes Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018
  • Figure 26: Herpes Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018
  • Figure 27: Herpes Therapeutics Market, Global, Treatment Algorithm
  • Figure 28: Herpes Therapeutics Market, Drivers and Restraints, 2012
  • Figure 29: Psoriasis Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018
  • Figure 30: Psoriasis Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018
  • Figure 31: Psoriasis Therapeutics Market, Global, Revenue Segmentation (%), 2011 and 2018
  • Figure 32: Psoriasis Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018
  • Figure 33: Psoriasis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018
  • Figure 34: Psoriasis Therapeutics Market, Global, Treatment Algorithm
  • Figure 35: Psoriasis Therapeutics Market, Drivers and Restraints, 2012
  • Figure 36: Acne Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018
  • Figure 37: Acne Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018
  • Figure 38: Acne Therapeutics Market, Global, Revenue Segmentation (%), 2011 and 2018
  • Figure 39: Acne Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018
  • Figure 40: Acne Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018
  • Figure 41: Acne Therapeutics Market, Global, Treatment Algorithm
  • Figure 42: Acne Therapeutics Market, Drivers and Restraints, 2012
  • Figure 43: Rosacea Therapeutics Market, Global, Revenue Forecasts ($bn), 2004-2018
  • Figure 44: Rosacea Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018
  • Figure 45: Rosacea Therapeutics Market, Global, Revenue Segmentation (%), 2010 and 2017
  • Figure 46: Rosacea Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018
  • Figure 47: Rosacea Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018
  • Figure 48: Rosacea Therapeutics Market, Global, Treatment Algorithm
  • Figure 49: Rosacea Therapeutics Market, Drivers and Restraints, 2012
  • Figure 50: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts ($m), 2004-2018
  • Figure 51: Atopic Dermatitis Therapeutics Market, Global, Revenue Forecasts by Geography ($m), 2004-2018
  • Figure 52: Atopic Dermatitis Therapeutics Market, Global, Revenue Segmentation (%), 2010 and 2017
  • Figure 53: Atopic Dermatitis Therapeutics Market, Global, Annual Cost of Treatment ($), 2004-2018
  • Figure 54: Atopic Dermatitis Therapeutics Market, Global, Treatment Usage Pattern (million), 2004-2018
  • Figure 55: Atopic Dermatitis Therapeutics Market, Global, Treatment Algorithm
  • Figure 56: Atopic Dermatitis Therapeutics Market, Drivers and Barriers, 2012
  • Figure 57: Dermatology Therapeutics Market to 2018, Drivers and Restraints, India, 2012
  • Figure 58: Dermatology Therapeutics Market, R&D Pipeline by Indication (%), 2012
  • Figure 59: Dermatology Therapeutics Market, Global, R&D Pipeline by Phase (%), 2012
  • Figure 60: Dermatology Therapeutics Market, Alopecia, R&D Pipeline by Phase (%), 2012
  • Figure 61: Dermatology Therapeutics Market, Herpes, R&D Pipeline by Phase (%), 2012
  • Figure 62: Dermatology Therapeutics Market, Psoriasis, R&D Pipeline by Phase (%), 2012
  • Figure 63: Dermatology Therapeutics Market, Acne Vulgaris, R&D Pipeline by Phase (%), 2012
  • Figure 64: Dermatology Therapeutics Market, Rosacea, R&D Pipeline by Phase (%), 2012
  • Figure 65: Dermatology Therapeutics Market, Atopic Dermatitis, R&D Pipeline by Phase (%), 2012
  • Figure 66: Dermatology Therapeutics Market, Global, Market Share of Top Manufacturers, 2011
  • Figure 67: Dermatology Therapeutics Market, Global, SWOT Analysis, Johnson & Johnson, 2012
  • Figure 68: Dermatology Therapeutics Market, Global, SWOT Analysis, Amgen, 2012
  • Figure 69: Dermatology Therapeutics Market, Global, SWOT Analysis, Merck, 2012
  • Figure 70: Dermatology Therapeutics Market, Global, SWOT Analysis, Abbott Laboratories, 2012
  • Figure 71: Dermatology Therapeutics Market, Global, SWOT Analysis, Pfizer, 2012
  • Figure 72: Dermatology Therapeutics Market, Global, SWOT Analysis, GlaxoSmithKline, 2012
  • Figure 73: Dermatology Therapeutics Market, Global, SWOT Analysis, Novartis AG, 2012
  • Figure 74: Dermatology Therapeutics Market, Global, SWOT Analysis, Medicis, 2012
  • Figure 75: Dermatology Therapeutics Market, Global, SWOT Analysis, Galderma, 2012
  • Figure 76: Dermatological Disorders Therapeutics Market, Global, Mergers and Acquisitions by Indication (%), 2009-2012
  • Figure 77: Dermatological Disorders Therapeutics Market, Mergers and Acquisitions by Year, 2009-2012
  • Figure 78: Dermatological Disorders Therapeutics Market, Mergers and Acquisitions by Type (%), 2009-2012
  • Figure 79: Dermatological Disorders Therapeutics Market, Mergers and Acquisitions by Value (%), 2009-2012
  • Figure 80: Dermatology Therapeutics Market, Mergers and Acquisitions by Geography (%), 2009-2012
  • Figure 81: Dermatology Therapeutics Market, Global, Licensing Agreements by Indication, 2009-2012
  • Figure 82: Dermatology Therapeutics Market, Global, Licensing Agreements by Year, 2009-2012
  • Figure 83: Dermatological Disorders Therapeutics Market, Global, Licensing Agreements by Value (%), 2009-2012
  • Figure 84: Dermatological Therapeutics Market, Global, Licensing Agreements by Geography, 2009-2012
  • Figure 85: Aesthetic Dermatology, Cosmetic and Reconstructive Plastic Surgery Trends, the US, 2011
  • Figure 86: Aesthetic Dermatology, Cosmetic Plastic Surgery Demographic Trends, the US, 2011
  • Figure 87: Aesthetic Dermatology, Drivers and Restraints, 2012
  • Figure 88: GBI Research Market Forecasting Model
Show More
Pricing